---
title: "Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress | EVAX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286109610.md"
description: "Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress | EVAX Stock News"
datetime: "2026-05-12T05:30:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286109610.md)
  - [en](https://longbridge.com/en/news/286109610.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286109610.md)
---

# Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress | EVAX Stock News

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress | EVAX Stock News

### Related Stocks

- [EVAX.US](https://longbridge.com/en/quote/EVAX.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection | APVO Stock News](https://longbridge.com/en/news/286261126.md)
- [Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial | EVAX Stock News](https://longbridge.com/en/news/283185262.md)
- [Cullinan Therapeutics wins FDA orphan drug designation for CLN-049 in relapsed AML](https://longbridge.com/en/news/286899965.md)
- [SELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progresses](https://longbridge.com/en/news/286279161.md)
- [Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition | SNDX Stock News](https://longbridge.com/en/news/286119621.md)